These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 92845)

  • 1. Successful immunocytochemical localization of myelin components in paraffin sections of human nervous tissue with preliminary observations on multiple sclerosis and metachromatic leukodystrophy lesions.
    Itoyama Y; Sternberger N; Quarles R; Webster HD; Richardson EP; Cohen S; Moser HW
    Trans Am Neurol Assoc; 1978; 103():216-9. PubMed ID: 92845
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions.
    Itoyama Y; Sternberger NH; Webster HD; Quarles RH; Cohen SR; Richardson EP
    Ann Neurol; 1980 Feb; 7(2):167-77. PubMed ID: 6154440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical method to identify myelin basic protein in oligodendroglia and myelin sheaths of the human nervous system.
    Itoyama Y; Sternberger NH; Kies MW; Cohen SR; Richardson EP; Webster H
    Ann Neurol; 1980 Feb; 7(2):157-66. PubMed ID: 6154439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions.
    Itoyama Y; Webster HD; Richardson EP; Trapp BD
    Ann Neurol; 1983 Sep; 14(3):339-46. PubMed ID: 6195956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases.
    Gendelman HE; Pezeshkpour GH; Pressman NJ; Wolinsky JS; Quarles RH; Dobersen MJ; Trapp BD; Kitt CA; Aksamit A; Johnson RT
    Ann Neurol; 1985 Sep; 18(3):324-8. PubMed ID: 2413798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: re-expression of a developmental gene in chronic lesions correlates with remyelination.
    Capello E; Voskuhl RR; McFarland HF; Raine CS
    Ann Neurol; 1997 Jun; 41(6):797-805. PubMed ID: 9189041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure and function of central nervous system myelin.
    Williams KA; Deber CM
    Crit Rev Clin Lab Sci; 1993; 30(1):29-64. PubMed ID: 7683887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG; Moscarello MA
    J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myelin diseases affecting both the central and the peripheral nervous system].
    Hagen K; Mellgren SI; Bovim G
    Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3600-2. PubMed ID: 9820004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the cerebral glycoconjugates in metachromic leukodystrophy (preliminary note)].
    Federico A; Guazzi GC; Milici N; Di Benedetta C
    Acta Neurol (Napoli); 1976; 31(3):245-9. PubMed ID: 138339
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA; Harauz G
    Int Rev Neurobiol; 2007; 79():149-72. PubMed ID: 17531841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis and pathomorphology of human leukodystrophies].
    Zhabotinskiĭ IuM; Shefer VF
    Arkh Patol; 1981; 43(11):86-92. PubMed ID: 7032481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin basic protein fragments in urine.
    Norton WT
    Ann Neurol; 1987 Nov; 22(5):656-7. PubMed ID: 2447827
    [No Abstract]   [Full Text] [Related]  

  • 14. Axons modulate myelin protein messenger RNA levels during central nervous system myelination in vivo.
    Kidd GJ; Hauer PE; Trapp BD
    J Neurosci Res; 1990 Aug; 26(4):409-18. PubMed ID: 1700137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy.
    Matzner U; Herbst E; Hedayati KK; Lüllmann-Rauch R; Wessig C; Schröder S; Eistrup C; Möller C; Fogh J; Gieselmann V
    Hum Mol Genet; 2005 May; 14(9):1139-52. PubMed ID: 15772092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis.
    Harauz G; Ishiyama N; Hill CM; Bates IR; Libich DS; Farès C
    Micron; 2004; 35(7):503-42. PubMed ID: 15219899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc as an inhibitor of myelin basic protein proteolytic breakdown in the central nervous system.
    Liuzzi GM; Ventola A; Rizzo T; Riccio P; Quagliariello E
    Acta Neurol (Napoli); 1991 Apr; 13(2):153-61. PubMed ID: 1716401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin basic protein immunoreactivity in the human embryonic CNS.
    Zecević N; Andjelković A; Matthieu JM; Tosić M
    Brain Res Dev Brain Res; 1998 Jan; 105(1):97-108. PubMed ID: 9497084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.